Introduction
The repeating unit carbohydrate moiety of laminin, N-acetyllactosamine, might play a role in the prevention of tumor metastasis. 1 A precursor of N-acetyllactosamine, 2,3,4,6-tetra-O-acetyl-b-D-galacto-pyranosyl-(14)-3,6-di-O-acetyl-2-azido-2-deoxy-D-glucopyranosyl nitrate was first prepared and purified, [2] [3] [4] [5] [6] and then used as the starting material in a synthesis of N-acetyllactosamine and its derivatives.
Results and discussion
2,3,4,6 -Tetra -O -acetyl -b -D -galactopyranosyl -(1 4)-3,6-di-O-acetyl-2-azido-2-deoxy-D-glucopyranosyl nitrate (1) 6 was treated with NaNO 2 and H 2 O in 1,4-dioxane for 10 h at 80°C to give hemiacetal 2, 7 which then reacted with CCl 3 CN and 1,8-diazabicyclo [5, 4 ,0]undec-7-ene (DBU) in dry CH 2 Cl 2 for 3 h at 0°C to give the imidate 3. Imidate 3 reacted with the spacer-arm aglycons in CH 2 Cl 2 at room temperature with Me 3 SiOTf as promoter to afford the b-glycosides (5 or 6) in yields of 65-70%. Treating 1 with LiBr 2 afforded bromide 4, which then reacted in the presence of tetrabutyl ammonium bromide (Bu 4 NBr) [8] [9] [10] with the spacer-arm aglycons to give the a-glycosides (7 or 8) in yields of 38-42% (Scheme 1).
When imidate 3 reacted with 5 or 6 in the presence of Me 3 SiOTf, the asymmetric divalent glycosides (9 and 10) were mainly obtained. On the other hand, BF 3 ·OEt 2 , a weaker promoter than Me 3 SiOTf, when used in the reaction of 3 and 5 or 6 gave the symmetric divalent glycosides (11 and 12) of b-configuration selectively. The a-symmetric divalent glycosides (13 and 14) were obtained selectively when 7 or 8 reacted with 3 in the presence of Me 3 SiOTf, but asymmetric divalent glycosides 9 or 10 were obtained when BF 3 ·OEt 2 was used in these reactions (Scheme 2).
Treating the azides 5-14 with thioacetic acid 11, 12 for 30 h at room temperature gave the corresponding acetamides 15-24 in yields of 48-80%, and these were deprotected to give the target compounds 25-34 in yields of 93-98% (Scheme 3).
The potential antimetastatic activity of compounds 25-34 was determined by measurements of inhibitory effects on cancer-cell attachment, spreading, and migra- 
8-Hydroxy
Compound 6 was prepared as described for the preparation of 5 and the crude product was purified by chromatography with 2:7 petroleum ether (60-90°C Compound 1 (1 g) was dissolved in anhydrous CH 3 CN (10 mL), and then LiBr (1 g) and 4 A , molecular sieves (2 g) were added. The mixture was stirred for 6 h at room temperature, the sieves were filtered off and the filtrate concentrated to give 4 (0.8 g) as a yellow syrup. 2 To a solution of 4 and diethylene glycol (1 mL) in dry CH 2 Cl 2 (15 mL), were added Bu 4 NBr (0.5 g) and 4 A , molecular sieves (1 g), and the mixture was stirred at room temperature for 24 h, the mixture was then To a solution of 3 (0.5 g, 0.65 mmol) and diethylene glycol (0.5 mL) in dry CH 2 Cl 2 (10 mL), Me 3 SiOTf was added and the mixture was stirred at room temperature for 16 h. The mixture was then diluted with CH 2 Cl 2 (20 mL) and washed with water, dried (Na 2 SO 4 ) and evap- A mixture of 3 (0.5 g, 0.65 mmol) and 5 (0.3 g, 0.42 mmol) in dry CH 2 Cl 2 (15 mL) in the presence of powered molecular sieves 4 A , (1 g) was cooled to −20°C and Me 3 SiOTf (0.1 mL) was added dropwise with stirring. The mixture was kept for 1 h at − 20 to 0°C and 24 h at room temperature, then the mixture was filtered and filtrate was washed with aqueous NaHCO 3 and water, dried (Na 2 SO 4 ) and concentrated. 
1-[2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl-(14)-3,6-di-O-acetyl-2-azido-2-deoxy-b-D-glucopyranosyloxy-8-[2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl-(1 4)-3,6-di-O-acetyl-2-azido-2-deoxy-a-D-glucopyranosyloxy-3-dioxaoctane (10)
Compound 10 was prepared as described for the preparation of 9. The crude product was purified by chromatography with 2:3 petroleum ether (60-90°C)-EtOAc to afford a colorless syrup in 40% yield; [ 
3-Oxapent-1,5-diyl bis[2,3,4,6-tetra-O-acetyl-b-Dgalactopyranosyl-(1 4)-3,6-di-O-acetyl-2-azido-2-deoxy-a-D-glucopyranoside] (13)
A mixture of 3 (0.5 g, 0.65 mmol) and 7 (0.3 g, 0.42 mmol) in dry CH 2 Cl 2 (15 mL) in the presence of powered molecular sieves 4 A , (1 g) was cooled to − 20°C and Me 3 SiOTf (0.1 mL) was added dropwise with stirring. The mixture was kept for 1 h at −20 to 0°C and 24 h at room temperature, then the mixture was filtered and the filtrate was washed with aqueous NaHCO 3 and water, dried (Na 2 SO 4 ) and concentrated. 
3,6-Dioxaoct-1,8-diyl bis[2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl-(1 4)-3,6-di-O-acetyl-2-azido-2-deoxy-a-D-glucopyranoside] (14)
Compound 14 was prepared as described for the preparation of 13. The crude product was purified by chromatography with 2:3 petroleum ether (60-90°C)-EtOAc to afford a colorless syrup in 39% yield; 
5-Hydroxy-3-oxapentyl 2,3,4,6-tetra-O-acetyl-b-Dgalactopyranosyl-(1 4)-3,6-di-O-acetyl-2-acetamido-2-deoxy-b-D-glucopyranoside (15)
A solution of 5 (0.2 g) in thioacetic acid (3 mL) was stirred at room temperature for 36 h, then concentrated. The residue was eluted from a column of silica gel with 50: Hydroxy-3-oxapentyl 2,3,4,6-tetra-O-acetyl-b-Dgalactopyranosyl-(14)-3,6-di-O-acetyl-2-acetamido-2-deoxy-a-D-glucopyranoside (17) Compound 17 was prepared as described for the preparation of 15. The crude product was purified by chro- , H-1%), 4.24 (dd, 1 H,  H-2), 4.47, 4.12-4.06 (m, 4 H, H-6a, 6b, H-6a%, 6b%),  3.94 (m, 1 H, H-5), 3.90 (m, 1 H, H-5%), 3.79 (m, 1 H,  H-4 A solution of 9 (0.25 g) in thioacetic acid (3 mL) was stirred for 50 h at room temperature, then concentrated. The residue was eluted from a column of silica gel with 40: Compound 20 was prepared as described for the preparation of 19. The crude product was purified by chromatography with 35: Compound 23 was prepared as described for the preparation of 19. The crude product was purified by chromatography with 35: 
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